• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV 蛋白与宿主限制因子的相互作用:对 HIV 感染潜在治疗干预的意义。

Interactions between HIV proteins and host restriction factors: implications for potential therapeutic intervention in HIV infection.

机构信息

Department of Infectious Diseases, Chongqing Public Health Medical Center, Chongqing, China.

School of science, University of Management and Technology, Lahore, Pakistan.

出版信息

Front Immunol. 2024 Aug 16;15:1390650. doi: 10.3389/fimmu.2024.1390650. eCollection 2024.

DOI:10.3389/fimmu.2024.1390650
PMID:39221250
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11361988/
Abstract

Different host proteins target different HIV proteins and antagonize their functions, depending on the stage of the HIV life cycle and the stage of infection. Concurrently, HIV proteins also target and antagonize various different host proteins to facilitate HIV replication within host cells. The preceding quite specific area of knowledge in HIV pathogenesis, however, remains insufficiently understood. We therefore propose, in this review article, to examine and discuss the HIV proteins that counteract those host restriction proteins which results directly in increased infectivity of HIV. We elaborate on HIV proteins that antagonize host cellular proteins to promote HIV replication, and thus HIV infection. We examine the functions and mechanisms via which Nef, Vif, Vpu, Env, Vpr, and Vpx counteract host proteins such as Ser5, PSGL-1, IFITMS, A3G, tetherin, GBP5, SAMHD1, STING, HUSH, REAF, and TET2 to increase HIV infectivity. Nef antagonizes three host proteins, viz., Ser5, PSGL1, and IFITIMs, while Vpx also antagonizes three host restriction factors, viz., SAMHD1, STING, and HUSH complex; therefore, these proteins may be potential candidates for therapeutic intervention in HIV infection. Tetherin is targeted by Vpu and Env, PSGL1 is targeted by Nef and Vpu, while Ser5 is targeted by Nef and Env proteins. Finally, conclusive remarks and future perspectives are also presented.

摘要

不同的宿主蛋白针对不同的 HIV 蛋白,并根据 HIV 生命周期和感染阶段拮抗其功能。同时,HIV 蛋白也针对和拮抗各种不同的宿主蛋白,以促进 HIV 在宿主细胞内的复制。然而,HIV 发病机制中前面提到的非常具体的知识领域仍然理解不足。因此,在这篇综述文章中,我们提出研究和讨论拮抗宿主限制蛋白的 HIV 蛋白,这直接导致 HIV 感染性增加。我们详细阐述了拮抗宿主细胞蛋白以促进 HIV 复制从而促进 HIV 感染的 HIV 蛋白。我们研究了 Nef、Vif、Vpu、Env、Vpr 和 Vpx 通过何种功能和机制拮抗 Ser5、PSGL-1、IFITMS、A3G、tetherin、GBP5、SAMHD1、STING、HUSH、REAF 和 TET2 等宿主蛋白,以增加 HIV 的感染性。Nef 拮抗三种宿主蛋白,即 Ser5、PSGL1 和 IFITIMs,而 Vpx 也拮抗三种宿主限制因子,即 SAMHD1、STING 和 HUSH 复合物;因此,这些蛋白可能是 HIV 感染治疗干预的潜在候选物。Tetherin 被 Vpu 和 Env 靶向,PSGL1 被 Nef 和 Vpu 靶向,而 Ser5 则被 Nef 和 Env 蛋白靶向。最后,还提出了结论性意见和未来展望。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fb1/11361988/469d07656fe9/fimmu-15-1390650-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fb1/11361988/469d07656fe9/fimmu-15-1390650-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fb1/11361988/469d07656fe9/fimmu-15-1390650-g001.jpg

相似文献

1
Interactions between HIV proteins and host restriction factors: implications for potential therapeutic intervention in HIV infection.HIV 蛋白与宿主限制因子的相互作用:对 HIV 感染潜在治疗干预的意义。
Front Immunol. 2024 Aug 16;15:1390650. doi: 10.3389/fimmu.2024.1390650. eCollection 2024.
2
HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef.HIV-1 组 P 无法通过 Vpu、Env 或 Nef 拮抗人 tetherin。
Retrovirology. 2011 Dec 15;8:103. doi: 10.1186/1742-4690-8-103.
3
Efficient Vpu-Mediated Tetherin Antagonism by an HIV-1 Group O Strain.一种HIV-1 O组毒株通过Vpu高效介导的对限制素的拮抗作用
J Virol. 2017 Feb 28;91(6). doi: 10.1128/JVI.02177-16. Print 2017 Mar 15.
4
HIV-1 Vpu Antagonizes CD317/Tetherin by Adaptor Protein-1-Mediated Exclusion from Virus Assembly Sites.HIV-1病毒蛋白U通过衔接蛋白1介导的排除作用,使其不参与病毒组装位点,从而拮抗CD317/束缚素。
J Virol. 2016 Jul 11;90(15):6709-6723. doi: 10.1128/JVI.00504-16. Print 2016 Aug 1.
5
HIV-1 Nef and Vpu are functionally redundant broad-spectrum modulators of cell surface receptors, including tetraspanins.HIV-1 Nef和Vpu是细胞表面受体(包括四跨膜蛋白)功能上冗余的广谱调节剂。
J Virol. 2014 Dec;88(24):14241-57. doi: 10.1128/JVI.02333-14. Epub 2014 Oct 1.
6
Tetherin/BST-2: Restriction Factor or Immunomodulator?束缚素/BST-2:限制因子还是免疫调节剂?
Curr HIV Res. 2016;14(3):235-46. doi: 10.2174/1570162x14999160224102752.
7
Multilayered and versatile inhibition of cellular antiviral factors by HIV and SIV accessory proteins.HIV 和 SIV 辅助蛋白对细胞抗病毒因子的多层次和多功能抑制。
Cytokine Growth Factor Rev. 2018 Apr;40:3-12. doi: 10.1016/j.cytogfr.2018.02.005. Epub 2018 Feb 23.
8
HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment.HIV-1 Vpu 和 HIV-2 Env 通过在核周隔室中的隔离来拮抗 BST-2/ tetherin。
Retrovirology. 2010 Jun 7;7:51. doi: 10.1186/1742-4690-7-51.
9
Spotlight on HIV-1 Nef: SERINC3 and SERINC5 Identified as Restriction Factors Antagonized by the Pathogenesis Factor.聚焦HIV-1 Nef:SERINC3和SERINC5被确定为受致病因子拮抗的限制因子。
Viruses. 2015 Dec 19;7(12):6730-8. doi: 10.3390/v7122970.
10
Preadaptation of Simian Immunodeficiency Virus SIVsmm Facilitated Env-Mediated Counteraction of Human Tetherin by Human Immunodeficiency Virus Type 2.猴免疫缺陷病毒 SIVsmm 的预适应促进了人类免疫缺陷病毒 2 型通过包膜介导拮抗人 tetherin
J Virol. 2018 Aug 29;92(18). doi: 10.1128/JVI.00276-18. Print 2018 Sep 15.

引用本文的文献

1
Mechanisms of Immune Evasion in HIV-1: The Role of Virus-Host Protein Interactions.HIV-1免疫逃逸机制:病毒-宿主蛋白相互作用的作用
Curr Issues Mol Biol. 2025 May 16;47(5):367. doi: 10.3390/cimb47050367.
2
Nanoscale warriors against viral invaders: a comprehensive review of Nanobodies as potential antiviral therapeutics.对抗病毒入侵者的纳米级战士:关于纳米抗体作为潜在抗病毒疗法的全面综述
MAbs. 2025 Dec;17(1):2486390. doi: 10.1080/19420862.2025.2486390. Epub 2025 Apr 9.
3
APOBEC3-Related Editing and Non-Editing Determinants of HIV-1 and HTLV-1 Restriction.

本文引用的文献

1
Disruption of Transmembrane Phosphatidylserine Asymmetry by HIV-1 Incorporated SERINC5 Is Not Responsible for Virus Restriction.HIV-1 整合的 SERINC5 破坏跨膜磷脂酰丝氨酸不对称性,但与病毒限制无关。
Biomolecules. 2024 May 10;14(5):570. doi: 10.3390/biom14050570.
2
Beyond Impairment of Virion Infectivity: New Activities of the Anti-HIV Host Cell Factor SERINC5.超越病毒感染力损伤:抗 HIV 宿主细胞因子 SERINC5 的新活性。
Viruses. 2024 Feb 12;16(2):284. doi: 10.3390/v16020284.
3
HIV-1 Nef Changes the Proteome of T Cells Extracellular Vesicles Depleting IFITMs and Other Antiviral Factors.
与载脂蛋白B mRNA编辑酶催化多肽样蛋白3相关的HIV-1和HTLV-1限制的编辑及非编辑决定因素
Int J Mol Sci. 2025 Feb 12;26(4):1561. doi: 10.3390/ijms26041561.
HIV-1 Nef 改变 T 细胞细胞外囊泡的蛋白质组,耗尽 IFITMs 和其他抗病毒因子。
Mol Cell Proteomics. 2023 Dec;22(12):100676. doi: 10.1016/j.mcpro.2023.100676. Epub 2023 Nov 7.
4
APOBEC3 degradation is the primary function of HIV-1 Vif determining virion infectivity in the myeloid cell line THP-1.APOBEC3 降解是 HIV-1 Vif 决定其在髓系细胞系 THP-1 中病毒感染力的主要功能。
mBio. 2023 Aug 31;14(4):e0078223. doi: 10.1128/mbio.00782-23. Epub 2023 Aug 9.
5
Antiviral HIV-1 SERINC restriction factors disrupt virus membrane asymmetry.抗病毒 HIV-1 SERINC 限制因子破坏病毒膜不对称性。
Nat Commun. 2023 Jul 20;14(1):4368. doi: 10.1038/s41467-023-39262-2.
6
HIV-1 subtype C Nef-mediated SERINC5 down-regulation significantly contributes to overall Nef activity.HIV-1 亚型 C 的 Nef 介导的 SERINC5 下调显著促进了 Nef 的整体活性。
Retrovirology. 2023 Mar 31;20(1):3. doi: 10.1186/s12977-023-00618-7.
7
The sound of silence: mechanisms and implications of HUSH complex function.寂静之声:HUSH复合体功能的机制及影响
Trends Genet. 2023 Apr;39(4):251-267. doi: 10.1016/j.tig.2022.12.005. Epub 2023 Feb 6.
8
The diverse roles of miRNAs in HIV pathogenesis: Current understanding and future perspectives.miRNAs 在 HIV 发病机制中的多种作用:当前的认识和未来的展望。
Front Immunol. 2023 Jan 5;13:1091543. doi: 10.3389/fimmu.2022.1091543. eCollection 2022.
9
Structural basis for HIV-1 antagonism of host APOBEC3G via Cullin E3 ligase.HIV-1 拮抗宿主 APOBEC3G 的结构基础:通过 Cullin E3 连接酶。
Sci Adv. 2023 Jan 4;9(1):eade3168. doi: 10.1126/sciadv.ade3168.
10
Glycosylation of viral proteins: Implication in virus-host interaction and virulence.病毒蛋白的糖基化:在病毒-宿主相互作用和毒力中的意义。
Virulence. 2022 Dec;13(1):670-683. doi: 10.1080/21505594.2022.2060464.